RBC Capital upgrades Convatec to ‘outperform’, hikes price target

by | Sep 7, 2023

(Sharecast News) – RBC Capital Markets upgraded ConvaTec on Thursday to ‘outperform’ from ‘sector perform’ and hiked the price target to 300p from 215p.
The bank said Wound Care execution could drive more than 5% upside to consensus revenue forecasts in 2027.

“ConvaTec is showing clear execution in Wound Care, which we estimate will contribute nearly half of group revenue growth to 2027E,” it said.

RBC said it would expect increased Wound Care volumes to lead to meaningful operating leverage in manufacturing and SG&A, plus meaningful mix benefits, leading to earnings growth meaningfully higher than revenue.

“Our top-down model indicates that continuing execution could imply circa 13% upside to consensus forecasts for Wound Care in 2027, or ,more than 5% upside to group revenue forecasts. We estimate that nearly half of ConvaTec’s growth in Wound Care will be through market share gains.

“We update our forecasts to include risk-adjusted estimates from our top-down model, leaving us 4.1% and 6.0% ahead of consensus on 2027E revenue and EPS respectively.

“We update our valuation methodology to reflect ConvaTec’s higher growth and margin profiles, leading us to increase our price target…and upgrade to outperform.”

Related articles

RBC Capital cuts Rentokil price target

RBC Capital cuts Rentokil price target

(Sharecast News) - RBC Capital Markets cut its price target on Rentokil Initial on Wednesday to 575p from 610p as it downgraded forecasts for forex and a greater back-end loading of TMX synergies, but said it believes the long-term story remains intact. The bank said...

Citi stays cautious about Experian on falling US credit flows

Citi stays cautious about Experian on falling US credit flows

(Sharecast News) - Citi has lifted its target price for data analytics and consumer credit reporting group Experian after a near-30% jump in the stock in the past two months, but has maintained a 'neutral' rating on the stock. Citi said back in August that while US...

Trending stories

Join our mailing list

Subscribe to our mailing list to receive regular updates!